Clinical impacts of diet and nutrition strategies on vascular inflammation and atherosclerosis: An update

Journal of Internal Medicine of Taiwan

Volumn 18, Issue 6, 2007, Pages 301-312

  Lin, Mike ^a,b  

^a GECC Kaohsiung   (Taiwan)

^b TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Coronary heart disease; Endothelial dysfunction; Endothelium; Proinflammatory cytokines; Vascular inflammation

Indexed keywords

ADIPONECTIN; ARGININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLAVONE DERIVATIVE; FOLIC ACID; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 2; LYCOPENE; MEVINOLIN; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; TAURINE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIET; ENDOTHELIAL DYSFUNCTION; FAT INTAKE; FRUIT; GRAIN; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFLAMMATION; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LOW FAT DIET; METABOLIC SYNDROME X; NUT; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PROTEIN INTAKE; REVIEW; RICE; SMOKING; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VEGETABLE; WINE;

EID: 38149086238     PISSN: 10167390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Chinese source.
2. Parkh P, McDaniel MC, Ashen MD, et al. Diets and cardiovascular disease. An evidence-based assessment. J Am Coll Cardiol 2005; 45: 1379-87.
3. Chinese source.
4. Grandy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-9F.
5. Weinber SL. The diet-heart hypothesis: a critique. J Am Coll Cardiol 2004; 43: 731-3.
6. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA 2002; 288; 2569-78.
7. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006; 48: 677-85.
8. Danignon J, Gamz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109 (Suppl 1): III27-32.
9. Hu FB, Willett WC. Diet, nutrition, and coronary heart disease. In: Douglas PS, editor. Cardiovascular Health and Disease in Women. 2nd ed. Philadelphia: W.B. Saunders Co. 2002; 71-92.
10. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
11. Ridker PM, Rifai N, Stampfer MJ, et al. plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-72.
12. Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-53.
13. Blankemberg S, Tiret L, Bickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30.
14. Lau DCW, Phillon B, Yan H, et al. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005; 288: H2031-41.
15. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adionectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-7.
16. Tataranni PA, Ortega E. A burning question. Does an adipokine-induced cultivation of the immune system mediate the effect of over nutrition on type 2 diabetes? Diabetes 2005; 54: 917-27.
17. Lindsay RS, Funahashi T, Hanson RL, et al. Adionectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-8.
18. Esposito K, Giagliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004; 14: 228-32.
19. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men. J Am Coll Cardiol 2006; 48: 1369-77.
20. Rothenbacher D, Brenner H, März W, Koenig W. Adionectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 2005; 26: 1640-6.
21. Foster-Powell K, Holt SHA, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002; 76: 5-56.
22. Williams S, Goedfine A, Timimi F, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-701.
23. Gingliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
24. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
25. DECODE study Group. Glucose tolerance and mortality. Comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-21.
26. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067-72.
27. Festa A, D'Agostino R Jr., Tracy R P, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in nondiabetic subjects: the Insulin Resistance Atherosclerotic study. Diabetic Med 2002; 19: 939-43.
28. Qi L, Rimm E, Liu S, RiFai N, Hu FB. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 2005; 28: 1022-28.
29. Esposito K, Nappo F, Giugliano F, et al. Meal modulation of circulation interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 2003; 78: 1135-40.
30. Sorensen LB, Raben A, Astrap A. Effect of sacrose on inflammatory markers in over weight humans. Am J Clin Nutr 2005; 82: 421-7.
31. Kang JX, Leaf A. Prevention of fatal arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr 2000; 71: 202S-7S.
32. Connor WE. Importance of n-3 fatty acids in health and disease. AmJ Clin Nutr 2000; 71: 171S-5S.
33. Von Shacky C. N-3 fatty acids and prevention of coronary atherosclerosis. Am J Clin Nutr 2000; 71: 224S-7S.
34. Brown AA, Hu FB. Dietrary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001; 73: 673-86.
35. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61: 345-58.
36. Pischon T, Han Kinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among U.S. men and women. Circulation 2003; 108: 155-60.
37. Djousse L, Pankov JS, Eckfieldt JH, et al. Relation between linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2001; 74: 612-9.
38. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004; 134: 1806-11.
39. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004; 350: 4-7.
40. Zampelas A, Panagiotakis DB, Pitsavos C, et al. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol 2005; 46: 120-4.
41. Fung TT, Rimm EB, Spiegelman D, et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001; 73: 61-7.
42. King DE, Egan BM, Geesey ME. Relation of dietary lat and fiber to elevation of C-reactive protein. Am J Cariol 2003; 92: 1335-9.
43. Tannock LR, O'Brien KD, Knopp RH, et al. Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 2005; 111: 3058-62.
44. Pirro M, Schillaci G, Sararese G, et al. Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffiness in subjects with hypercholesterolemia. Eur J Cardiovasc Prev Rehabil 2004; 11: 497-502.
45. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-9.
46. Sharman MJ, Volek JS. Weight loss leads to reductions in inflammatory biomarkers after a very-low carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond) 2004; 107: 365-9.
47. Rissanen TH, Voutilainen S, Virtanen JK, et al. Low intake of fruits, berries, and vegetables is associated with excess mortality in men: the Knopio Ischemic Heart Disease Risk Factors (KIHD) study. J Nutr 2003; 133: 199-204.
48. Gao X, Bermuder OI, Tucker KL. Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr 2004; 134: 913-8.
49. Maron DJ. Flavonoids for reduction of atherosclerotic risk. Curr Atheroscler Rep 2004; 6: 73-8.
50. Brighcnti F, Valtuena S, Pellegrini N, et al. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr 2005; 93: 619-25.
51. Van Herpen-Broekmans VM, Klopping-Ketelaars IA, Bets ML, et al. Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol 2004; 19: 915-21.
52. Ajani UA, Ford ES, Mokdad AL. Dietary fiber and C-reactive protein: findings from National Health and Nutrition Examination Survey Data. J Nutr 2004; 134: 1181-5.
53. Sanchez Moreno C, Cano MP, de Ancos B, et al. High-pressurized orange juice consumption affects plasma vitamin C, antioxidcont status and inflammatory markers in healthy humans. J Nutr 2003; 133: 2204-9.
54. Watzl B, Kulling SE, Maseneder J, Barth SW, Bub A. A 4-week intervention with high intake of carotenoid-rich vegetablese and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 2005; 82: 1052-8.
55. Freese R, Vaarala O, Turpeinen AM, Mutanen M. No difference in matelet activation or inflammatory markers after diets rich or poor in vegetables, berries and apple in healthy subjects. Eur J Nutr 2004; 43: 175-82.
56. Kris-Etherofon P. Monounsaturated fatty acids and risk of cardiovascular disease. Circulation 1999; 100: 1253-8.
57. Wells BJ, Mainous AG 3rd, Eveerett CJ. Association between dietary arginine and C-reactive protein. Nutrition 2005; 21: 125-30.
58. Corrao G, Rubbiati L, Bagnardi V, et al. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000; 95: 1505-23.
59. Imhof A, Frochlich M, Brenner H, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.
60. Albert MA, Glynn RJ, Ridker PM, et al. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107: 443-7.
61. Stewart SH, Mainous AG, Gilbert G, et al. Relation between alcohol consumption and C-reactive protein levels in the adult U.S. population. J Am Bord Fam Pract 2002; 15: 437-42.
62. Imhof A, Woodward M, Doering A, et al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in Western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 2004; 25: 2092-100.
63. Levitan EB, Ridker PM, Manson JE, et al. Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years. Am J Cardiol 2005; 96: 83-8.
64. Sierksma A, Van Der Gaag MS, Kluft C, et al. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 2002; 56: 1130-6.
65. Estruch R, Sacanella E, Badia E, et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effect of wine on inflammatory markers. Atherosclerosis 2004; 175: 117-23.
66. Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004; 80: 1029-35.
67. Schulze MB, Hoffman K, Manson JE, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 2005; 82: 675-84.
68. Fredrikson GN, Hedblad B, Nilsson JA, Alm R, Berglund G, Nilsson J. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 2004; 53: 1436-42.
69. Jenkins DJA, Kendall CWC, Marchie A, et al. Effects of a dietary portfolio cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 2003; 290: 502-10.
70. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek Population. N Engl J Med 2003; 348: 2599-608.
71. Chrysohoou C, Panagiotakis DB, Pitsavos C, et al. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA study. J Am Coll Cardiol 2004; 44: 152-8.
72. Fung TT, McCullough ML, Newby PK, et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2005; 82: 163-73.
73. De Lorgeri M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
74. Singh RB, Dubnov G, Niaz MA, et al. Effect of Indo-Mediterranean diet on progression of coronary disease in high risk patients: a randomized single blind trial. Lancet 2002; 360: 1455-61.
75. Horton R. Expression of concern: Indo-Mediterranean Diet Heart Study. Lancet 2005; 366: 354-6.
76. Barr ML, Gilbert JH, Holliday RM, et al. Effects of changes in fat, fish, and fiber intakes on death and myocardial reinfarction: Diet and Reinfarction Trial DART). Lancet 1989; 2: 757-61.
77. GISSI-Prevention Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamine E after myocardial infarction: results of the GISSI-Prevention trial. Lancet 1999; 354: 447-55.
78. Blum A, Hathaway L, Mincemoyer R, et al. Effect of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy post menopausal women. J Am Coll Cardiol 2000; 35: 271-76.
79. Cooke JP. Nutricenticals for cardiovascular health. Am J Cardiol 1998; 82(10A): 43S-5S.
80. Grundy S M, Brewerb HB, Cleeman JI, et al. Definition of metabolic syndrome. Circulation 2004; 109: 433-8.
81. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002: 287: 356-9.
82. Williams DE, Prevost AT, Whichelow MJ, et al. A corss-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome. Br J Nutr 2000; 83: 257-66.
83. McKeown NM, Meigs JB, Liu S, et al. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham offspring Cohort. Diabetes Care 2004; 27: 538-46.
84. Panagiotakis DB, Pitsavos CH, Chrysohoou C, et al. The impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004; 147: 106-12.
85. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440-6.
86. Van Gaal LF, Rissanen AM, Scheen AJ, et al. RIO-Europe study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweigh patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389-97.
87. Esposito K, Giugliano D. Effect of rimonabant on weight reduction and cardiovascular risk. Lancet 2005; 366: 367-368.
88. Erlinger TP, Miller ERIII, Charleston J, et al. Inflammation modifies the effects of reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation. 2003; 108: 150-4.
89. The World Health Report 2004. Global strategy on diet-physical activity, and Health. Geneva: World Health Organization, 2004.
90. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293: 1861-7.